Vanda Pharmaceuticals
VNDA
$4.81
Share price
4.12%
Change (1 day)
-21.66%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - P/B ratio
P/B ratio as of April 2024 : 0.4878
According to Vanda Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.4878.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Vanda Pharmaceuticals - P/B ratio (from 2006 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.4456 | -43.83% |
| 2022-12-31 | 0.7933 | -54.18% |
| 2021-12-31 | 1.73 | 8.84% |
| 2020-12-31 | 1.59 | -25.62% |
| 2019-12-31 | 2.14 | -57.05% |
| 2018-12-31 | 4.98 | -4.21% |
| 2017-12-31 | 5.20 | -2.62% |
| 2016-12-31 | 5.34 | 78.12% |
| 2015-12-31 | 3.00 | -18.89% |
| 2014-12-31 | 3.69 | -60.6% |
| 2013-12-31 | 9.38 | -11.12% |
| 2012-12-31 | 10.5 | 163.86% |
| 2011-12-31 | 4.00 | -43.13% |
| 2010-12-31 | 7.03 | -47.79% |
| 2009-12-31 | 13.5 | 4550.29% |
| 2008-12-31 | 0.2896 | -86.78% |
| 2007-12-31 | 2.19 | -89.26% |
| 2006-12-31 | 20.4 | |
| 2005-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | 949.67% | 🇺🇸 USA |
 Novartis NVS | 5.03 | 931.74% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.61 | 230.21% | 🇺🇸 USA |
 Eli Lilly LLY | 64.2 | 13,059.32% | 🇺🇸 USA |
 Merck MRK | 8.83 | 1,710.15% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 3.08 | 531.97% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | 0.7970 | 63.37% | 🇺🇸 USA |